BB Biotech's total assets for Q3 2024 were CHF2.51B, a decrease of -7.50% from the previous quarter. CH:BION total liabilities were CHF277.23M for the fiscal quarter, a -14.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.